A “life changing” new therapy for an extremely rare medical condition which causes patients to grow a second skeleton has been proven successful in a key clinical trial.
Relatives of people living with fibrodysplasia ossificans progressiva (FOP) say that they have “desperately waited” years for a medicine to “stop the disease in its tracks”.
